rachael klein
customer operations manager at corcept therapeutics
biotechnology, operations
san francisco, california, united states
Gather verified email addresses & phone numbers directly from LinkedIn
202M+
Contacts
44M+
Companies
57M+
Emails
9M+
Phone numbers
territory manager
Unlock verified emails, phone numbers, and more.
See full contact details in OrionProfessional Email
****@****.com
Personal Email
****@****.com
Work Phone
(***) ***-***
Mobile
(***) ***-***
Local Location
seattle, washington, united states
HQ Location
redwood city, california, united states
Industry
pharmaceuticals, sales
Designation
territory manager
Birthday
-
HQ Location
redwood city, california, united states
Industry
biotechnology research
Employees
536
Founded
1998
Specialties

Install the Orion chrome extension from the Web Store. Sign up using your email address.

The Extension will sync with your LinkedIn from where you can discover in-depth Prospects' profiles, company information and Find Similar details.

Get detailed insights of Prospects Company Profile, Email ID, Phone Number, Location or Similar Designation and much more.
1
Number of Companies Worked For
kelly erickson is currently employed at Corcept therapeutics. kelly is an experienced professional working at Corcept Therapeutics as the territory manager. kellys phone number is (***) ***-*** and email is ****@****.com to get more information install Orion extension.
kelly erickson is currently employed at Corcept therapeutics.
At present, kelly erickson is serving as the territory manager.
The professional email used by kelly erickson is ****@****.com.
kelly erickson's professional contact number is (***) ***-***.
Rachael Klein are some of the colleagues working with kelly erickson.
Wendi Mitchell, Michelle Wang, Derrick Melanson, Ken Anders, Darrill Continent are some of the other counterparts holding the similar designation in other organizations like kelly erickson.
kelly erickson has worked for corcept therapeuticsfalse so far.
According to the Corcept therapeutics Summary, We’ve been unlocking the potential of cortisol modulation for more than 25 years. We’re leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR). To date, we have discovered more than 1,000 selective proprietary cortisol modulators. In 2012, we received FDA approval of a groundbreaking cortisol receptor blocker and the first approved treatment for hypercortisolism (Cushing’s syndrome). Today, our team and collaborators continue to unlock the possibilities of cortisol modulation as a way to treat serious diseases. With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advancing the possibilities of cortisol modulation. What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease..
The company is headquartered at Redwood city, California, United states.
kelly erickson is territory manager at Corcept therapeutics.
kelly erickson is currently residing in seattle, washington, united states.
kelly erickson is currently working with the pharmaceuticals, sales industry.
Nearly 536 is the total headcount of the company.
customer operations manager at corcept therapeutics
biotechnology, operations
san francisco, california, united states